|
Infrared coagulation
(IRC), also called photocoagulation,
is used to treat symptomatic first-degree and
second-degree internal hemorrhoids. Pulses of infrared
radiation are applied to the hemorrhoidal base through a hand-held applicator. These
pulses produce a discreet area of necrosis, which heals
to form a scar. This reduces or eliminates blood flow
through the hemorrhoid, thereby shrinking it, and the
mucosa becomes fixed to the underlying tissue. The
procedure is easily performed in a physician’s office.
Infrared coagulation is considered
medically necessary for first-degree or
second-degree (i.e., Grade I or Grade II) internal
hemorrhoids that are painful or persistently bleeding. A
maximum of four treatments within a six-month
period are considered medically necessar
Internal hemorrhoids are graded as
follows:
Grade I: Bleeding without prolapse
Grade II: Prolapse with spontaneous reduction (with
or without bleeding)
Grade III: Prolapse with manual reduction
Grade IV: Incarcerated, irreducible prolapse
This system has been in place for many
years and correlates relatively well with treatment
algorithms (i.e., Grade I and II hemorrhoids are often
successfully treated by nonoperative means while Grade
III and Grade IV hemorrhoids are more likely to require
surgery).
Infrared coagulation (IRC) is one of
several non-surgical treatments for the management of
hemorrhoids. The infrared photocoagulator generates
infrared radiation that coagulates tissue protein and
evaporates water from cells. The amount of destruction
depends upon the intensity and the duration of
application. Usually three to four applications are
enough to achieve coagulation of each hemorrhoid. The
infrared coagulator is not particularly effective in
treating large amounts of prolapsing tissue, therefore
is most beneficial in Grade I and small Grade II
hemorrhoids. It has been described to be slightly less
painful than rubber banding.
The American Society of Colon & Rectal
Surgeons practice parameters for the treatment of
hemorrhoids notes that controlled trials indicate that
IRC is useful for first-degree and second-degree
hemorrhoids; however, first-degree and second-degree
hemorrhoids may need repetitive treatments and
alternative methods may be more efficacious (i.e.,
rubber band ligations). Generally, when additional
treatments are necessary, they are one month apart
(MacKay, 2001).
In a randomized study, Gupta compared infrared
coagulation and rubber band ligation (RBL) in terms of
effectiveness and discomfort (Gupta, 2003). One hundred
patients with second-degree bleeding hemorrhoids were
randomized prospectively to either RBL (N=54) or
infrared coagulation (N=46). Parameters measured
included postoperative discomfort and pain, time to
return to work, relief in incidence of bleeding, and
recurrence rate. Pain was assessed using a visual
analogue scale from “0” (no pain at all) to “10” (the
worst pain the patient had ever experienced).
Postoperative pain during the first week was stronger in
the band ligation group (2-5 versus 0-3 on a visual
analogue scale). Post-defecation pain and rectal
tenesmus was more intense with band ligation. The
patients in the infrared coagulation group resumed their
duties earlier (2 versus 4 days), but also had a higher
recurrence or failure rate. The author concluded that
band ligation, although more effective in controlling
symptoms and obliterating hemorrhoids, is associated
with more pain and discomfort to the patient. As
infrared coagulation can be conveniently repeated in
case of recurrence, it could be considered to be a
suitable alternative office procedure for the treatment
of early stage hemorrhoids.
Accarpio and colleagues (2002) reported on results of
7850 cases of non-surgical outpatient treatment of
hemorrhoids with a combined technique. The patients
received a combined treatment consisting of
sclerotherapy, rubber band ligation, and infrared
coagulation. On the first visit, patients underwent
sclerotherapy to decongest the area and reduce the size
of the prolapse, when present. Fifteen days later,
rubber band ligation was performed with infrared
coagulation on the tissue strangulated by the rubber
band. This combined treatment was repeated every 15
days until complete obliteration of all redundant
hemorrhoidal tissue was achieved, as well as relief of
symptoms. This usually took a total of three
treatments; rarely up to seven treatments were
necessary.
Linares and colleagues (2001) prospectively studied
the effectiveness of the treatment of internal
hemorrhoids with rubber band ligation (RBL) and infrared
photocoagulation (IRC) in 358 patients with a total of
817 hemorrhoid groups and follow-up period of 36 months.
The mean number of hemorrhoids treated per patients was
2.3. Rubber band ligation was performed with McGown
ligator and suction pump, placing the band at the base
of the hemorrhoid. Infrared coagulation was performed
with Lumatec coagulation system, applying at least four
shoots around each hemorrhoid, with an exposition time
ranging between 1 and 1.5 seconds. Treatment was
considered effective when patients became asymptomatic
(relief of pain, bleeding, or anal itching) and the
obliteration of hemorrhoids after the treatment was
confirmed by anal inspection and anoscopy. Of the 358
patients, 295 were treated with RBL (82.4%). This
treatment was effective in 98% of the patients after 180
days and very good after 36 months. There were 6/295
relapses at 36 months (2%). Those treated with IRC
included 63 of 358 patients (17.6%). In this group,
relapses were observed in 6/63 patients (9.5%) at 36
months, all of them with grade III hemorrhoids that
required additional treatment with RBL. The treatment
with RBL or IRC depended on the number of hemorrhoids
and the hemorrhoidal grade. No significant differences
were found regarding the effectiveness between RBL and
IRC for the treatment of grade I-II hemorrhoids, while
RBL was more effective for grade III and IV
hemorrhoids. The authors concluded that RBL and IRC
should be considered as a good treatment for all grades
of hemorrhoids, due to its effectiveness, its
cost-benefit and its small short and long-term
morbidity.
A literature search from January 2006 to March 2007
resulted in no new published literature that would
change the current guideline. |